{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T18:00:45Z","timestamp":1794592845254,"version":"4.9.1"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20221522"],"award-info":[{"award-number":["BK20221522"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473781"],"award-info":[{"award-number":["82473781"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173652"],"award-info":[{"award-number":["82173652"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bioorg.2025.109378","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T07:47:03Z","timestamp":1765957623000},"page":"109378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Metabolomics accelerates drug development and facilitates the discovery of new targets, mechanisms and structures"],"prefix":"10.1016","volume":"169","author":[{"given":"Yu","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baichen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoaoyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiying","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haopeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.bioorg.2025.109378_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20194781","article-title":"The need for multi-omics biomarker signatures in precision medicine","volume":"20","author":"Olivier","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and metabolic diseases: where do we stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.molcel.2015.04.021","article-title":"Defining the metabolome: size, flux, and regulation","volume":"58","author":"Zamboni","year":"2015","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrm3314","article-title":"Innovation: Metabolomics: the apogee of the omics trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0025","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tibs.2017.01.004","article-title":"Metabolomics: a primer","volume":"42","author":"Liu","year":"2017","journal-title":"Trends Biochem. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109378_bb0030","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nrm.2016.25","article-title":"Metabolomics: beyond biomarkers and towards mechanisms","volume":"17","author":"Johnson","year":"2016","journal-title":"Nat.Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109378_bb0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41580-019-0108-4","article-title":"Identification of bioactive metabolites using activity metabolomics","volume":"20","author":"Rinschen","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109378_bb0040","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ajg.2013.407","article-title":"How drugs are developed and approved by the FDA: current process and future directions","volume":"109","author":"Ciociola","year":"2014","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109378_bb0045","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrd.2016.32","article-title":"Emerging applications of metabolomics in drug discovery and precision medicine","volume":"15","author":"Wishart","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109378_bb0050","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.drudis.2022.02.018","article-title":"Recent advances in metabolomics analysis for early drug development","volume":"27","author":"Alarcon-Barrera","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.109378_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1142287","article-title":"Mass spectrometry-based metabolomics for discovering active ingredients and exploring action mechanism of herbal medicine","volume":"11","author":"Guo","year":"2023","journal-title":"Front Chem."},{"key":"10.1016\/j.bioorg.2025.109378_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.trac.2019.05.030","article-title":"Mass spectrometry-based non-targeted metabolic profiling for disease detection: recent developments","volume":"118","author":"Zang","year":"2019","journal-title":"Trends Anal. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109378_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/metabo9070123","article-title":"NMR spectroscopy for metabolomics research","volume":"9","author":"Emwas","year":"2019","journal-title":"Metabolites"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0070","first-page":"630","article-title":"NMR-based approaches for lead discovery","volume":"5","author":"Wyss","year":"2002","journal-title":"Curr. Opin. Drug Discov. Devel."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0075","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-anchem-091620-015205","article-title":"Current challenges and recent developments in mass spectrometry-based metabolomics","volume":"14","author":"Collins","year":"2021","journal-title":"Annu Rev Anal Chem (Palo Alto, Calif)"},{"issue":"7","key":"10.1016\/j.bioorg.2025.109378_bb0080","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41592-021-01197-1","article-title":"Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices","volume":"18","author":"Alseekh","year":"2021","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109378_bb0085","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/mas.21785","article-title":"Recent advances in LC-MS-based metabolomics for clinical biomarker discovery","volume":"42","author":"Chen","year":"2023","journal-title":"Mass Spectrom. Rev."},{"issue":"16","key":"10.1016\/j.bioorg.2025.109378_bb0090","doi-asserted-by":"crossref","first-page":"9897","DOI":"10.1021\/acs.analchem.8b02098","article-title":"Combination of droplet extraction and Pico-ESI-MS allows the identification of metabolites from single cancer cells","volume":"90","author":"Zhang","year":"2018","journal-title":"Anal. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109378_bb0095","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41592-021-01182-8","article-title":"Metabolomic profiling of single enlarged lysosomes","volume":"18","author":"Zhu","year":"2021","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109378_bb0100","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1021\/acs.analchem.5b04749","article-title":"Single-cell analysis using drop-on-demand inkjet printing and probe electrospray ionization mass spectrometry","volume":"88","author":"Chen","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bioorg.2025.109378_bb0105","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-biochem-061516-044952","article-title":"Metabolite measurement: pitfalls to avoid and practices to follow","volume":"86","author":"Lu","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.bioorg.2025.109378_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9831-9_1","article-title":"Single-cell metabolomics by mass spectrometry","volume":"2064","author":"Shrestha","year":"2020","journal-title":"Methods Mol. Biol."},{"issue":"6163","key":"10.1016\/j.bioorg.2025.109378_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/science.1243259","article-title":"Single-cell metabolomics: analytical and biological perspectives","volume":"342","author":"Zenobi","year":"2013","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/metabo6010010","article-title":"Cancer metabolomics and the human metabolome database","volume":"6","author":"Wishart","year":"2016","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0125","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11481-009-9157-3","article-title":"Database resources in metabolomics: an overview","volume":"5","author":"Go","year":"2010","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"417","key":"10.1016\/j.bioorg.2025.109378_bb0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal4599","article-title":"What evidence do we need for biomarker qualification?","volume":"9","author":"Leptak","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55952-8","article-title":"Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer","volume":"9","author":"Martin-Blazquez","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109378_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.969770","article-title":"Design, synthesis and cytotoxic evaluation of novel betulonic acid-diazine derivatives as potential antitumor agents","volume":"10","author":"Shu","year":"2022","journal-title":"Front Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-18361-y","article-title":"Investigation of pathogenesis of hyperuricemia based on untargeted and targeted metabolomics","volume":"12","author":"Qin","year":"2022","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.bioorg.2025.109378_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238237","article-title":"The therapeutic effect and the potential mechanism of flavonoids and phenolics of moringa oleifera lam. leaves against hyperuricemia mice","volume":"27","author":"Luo","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2025.109378_bb0155","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1021\/pr400872j","article-title":"Metabolomics reveals metabolite changes in acute pulmonary embolism","volume":"13","author":"Bujak","year":"2014","journal-title":"J. Proteome Res."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109378_bb0160","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1021\/acs.jproteome.7b00206","article-title":"High-throughput metabolomics for discovering potential metabolite biomarkers and metabolic mechanism from the APPswe\/PS1dE9 transgenic model of alzheimer's disease","volume":"16","author":"Yu","year":"2017","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0165","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s13311-018-0669-5","article-title":"L-norvaline reverses cognitive decline and synaptic loss in a murine model of alzheimer's disease","volume":"15","author":"Polis","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0170","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41392-023-01311-z","article-title":"Application of metabolomics in urolithiasis: the discovery and usage of succinate","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-20638-1","article-title":"Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics","volume":"12","author":"Hirakawa","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0180","article-title":"Untargeted metabolomics and transcriptomics identified glutathione metabolism disturbance and PCS and TMAO as potential biomarkers for ER stress in lung","volume":"11","author":"Wang","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109378_bb0185","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0190","first-page":"561","article-title":"Antisense and RNAi: powerful tools in drug target discovery and validation","volume":"6","author":"Lavery","year":"2003","journal-title":"Curr. Opin Drug Discov. Devel."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109378_bb0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1359-6446(02)02234-1","article-title":"Transgenic systems in drug discovery: from target identification to humanized mice","volume":"7","author":"Tornell","year":"2002","journal-title":"Drug Discov. Today"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109378_bb0200","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1021\/acs.jproteome.8b00028","article-title":"Multiplatform metabolomics investigation of antiadipogenic effects on 3T3-L1 adipocytes by a potent diarylheptanoid","volume":"17","author":"Du","year":"2018","journal-title":"J. Proteome Res."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109378_bb0205","doi-asserted-by":"crossref","first-page":"9567","DOI":"10.1074\/jbc.RA118.007302","article-title":"MetAP2 inhibition increases energy expenditure through direct action on brown adipocytes","volume":"294","author":"Huang","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41537-022-00273-5","article-title":"Targeted metabolomics reveals aberrant profiles of serum bile acids in patients with schizophrenia","volume":"8","author":"Qing","year":"2022","journal-title":"Schizophrenia (Heidelb)"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0215","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41467-023-36708-5","article-title":"PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109378_bb0220","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0225","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cbpa.2006.06.022","article-title":"Streamlining lead discovery by aligning in silico and high-throughput screening","volume":"10","author":"Davies","year":"2006","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109378_bb0230","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1742-4658.2007.05673.x","article-title":"Metabonomics in pharmaceutical R&D","volume":"274","author":"Lindon","year":"2007","journal-title":"FEBS J."},{"key":"10.1016\/j.bioorg.2025.109378_bb0235","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd728","article-title":"Metabonomics: a platform for studying drug toxicity and gene function","volume":"1","author":"Jeremy","year":"2002","journal-title":"NAT. REV. | DRUG DISCOVERY"},{"issue":"18","key":"10.1016\/j.bioorg.2025.109378_bb0240","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1002\/(SICI)1522-2683(19991201)20:18<3647::AID-ELPS3647>3.0.CO;2-#","article-title":"An integrated proteomic approach to studying glomerular nephrotoxicity","volume":"20","author":"Cutler","year":"1999","journal-title":"Electrophoresis"},{"issue":"3","key":"10.1016\/j.bioorg.2025.109378_bb0245","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/MCB.19.3.1720","article-title":"Correlation between protein and mRNA abundance in yeast","volume":"19","author":"Gygi","year":"1999","journal-title":"Mol. Cell. Biol."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109378_bb0250","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1128\/JB.180.19.5109-5116.1998","article-title":"Effect of slow growth on metabolism of Escherichia coli, as revealed by global metabolite pool (\"metabolome\") analysis","volume":"180","author":"Tweeddale","year":"1998","journal-title":"J. Bacteriol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109378_bb0255","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/cbdv.200690065","article-title":"Cluster analysis as selection and dereplication tool for the identification of new natural compounds from large sample sets","volume":"3","author":"Boroczky","year":"2006","journal-title":"Chem. Biodivers."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109378_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103460","article-title":"Metabolomics- and systems-biology-guided discovery of metabolite lead compounds and druggable targets","volume":"28","author":"Palermo","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.109378_bb0265","first-page":"7","article-title":"Combining evolutionary inference and metabolomics to identify plants with medicinal potential","author":"Mawalagedera","year":"2019","journal-title":"Front. Ecol. Evol."},{"key":"10.1016\/j.bioorg.2025.109378_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.728256","article-title":"Chinmedomics strategy for elucidating the pharmacological effects and discovering bioactive compounds from keluoxin against diabetic retinopathy","volume":"13","author":"Kong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109378_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115961","article-title":"Isolation and identification of angiogenesis-promoting components in Huanglian Jiedu decoction using live cell bio-specific extraction","volume":"303","author":"Liao","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.109378_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106281","article-title":"Chemical constituents from the stems and leaves of Amomum villosum Lour. and their anti-inflammatory and antioxidant activities","volume":"131","author":"Gao","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109378_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154503","article-title":"Material basis and integrative pharmacology of danshen decoction in the treatment of cardiovascular diseases","volume":"108","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2025.109378_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103287","article-title":"Metabolomic analysis of a selective ABCA1 inducer in obesogenic challenge provides a rationale for therapeutic development","volume":"66","author":"Lewandowski","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bioorg.2025.109378_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106378","article-title":"Mass spectrometry-based metabolomics approach and in vitro assays revealed promising role of 2,3-dihydroquinazolin-4(1H)-one derivatives against colorectal cancer cell lines","volume":"182","author":"Dahabiyeh","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2025.109378_bb0300","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiz534","article-title":"A novel antiparasitic compound kills ring-stage plasmodium falciparum and retains activity against artemisinin-resistant parasites","volume":"221","author":"Clements","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bioorg.2025.109378_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106230","article-title":"Cyclo-(Phe-Tyr) as a novel cyclic dipeptide compound alleviates ischemic\/reperfusion brain injury via JUNB\/JNK\/NF-kappaB and SOX5\/PI3K\/AKT pathways","volume":"180","author":"Cai","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cbi.2004.09.008","article-title":"Accurate prediction of human drug toxicity: a major challenge in drug development","volume":"150","author":"Li","year":"2004","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109378_bb0315","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2217\/14622416.6.7.691","article-title":"The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements","volume":"6","author":"Lindon","year":"2005","journal-title":"Pharmacogenomics"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109378_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102682","article-title":"Glucagon-like peptide-1 analog liraglutide leads to multiple metabolic alterations in diet-induced obese mice","volume":"298","author":"Park","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0325","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/embor.2008.236","article-title":"Reading the metabolic fine print: the application of metabolomics to diagnostics, drug research and nutrition might be integral to improved health and personalized medicine","volume":"10","author":"Hunter","year":"2009","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bioorg.2025.109378_bb0330","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13020-018-0218-5","article-title":"Application of metabolomics in toxicity evaluation of traditional Chinese medicines","volume":"13","author":"Duan","year":"2018","journal-title":"Chin. Med."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109378_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/metabo14020098","article-title":"Metabolomics in preclinical drug safety assessment: current status and future trends","volume":"14","author":"Sille","year":"2024","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.dmpk.2015.10.002","article-title":"Application of metabolomics to toxicology of drugs of abuse: a mini review of metabolomics approach to acute and chronic toxicity studies","volume":"31","author":"Zaitsu","year":"2016","journal-title":"Drug Metab. Pharmacokinet"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109378_bb0345","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00204-015-1519-4","article-title":"Translational biomarkers of acetaminophen-induced acute liver injury","volume":"89","author":"Beger","year":"2015","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.bioorg.2025.109378_bb0350","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1007\/s00204-015-1655-x","article-title":"Comparative metabonomic analysis of hepatotoxicity induced by acetaminophen and its less toxic meta-isomer","volume":"90","author":"Kyriakides","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.bioorg.2025.109378_bb0355","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.taap.2019.04.001","article-title":"Mechanistic identification of biofluid metabolite changes as markers of acetaminophen-induced liver toxicity in rats","volume":"372","author":"Pannala","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2025.109378_bb0360","first-page":"157","article-title":"Mechanisms of acetaminophen hepatotoxicity and their translation to the human pathophysiology","volume":"3","author":"Ramachandran","year":"2017","journal-title":"J. Clin. Transl. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109378_bb0365","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0192623309332992","article-title":"Discovery of metabolomics biomarkers for early detection of nephrotoxicity","volume":"37","author":"Boudonck","year":"2009","journal-title":"Toxicol. Pathol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109378_bb0370","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.toxlet.2014.07.021","article-title":"Detection of hepatotoxicity potential with metabolite profiling (metabolomics) of rat plasma","volume":"230","author":"Mattes","year":"2014","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.bioorg.2025.109378_bb0375","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2012.05.019","article-title":"(1)H NMR-based metabonomics in brain nucleus accumbens and striatum following repeated cocaine treatment in rats","volume":"218","author":"Li","year":"2012","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.bioorg.2025.109378_bb0380","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1194\/jlr.M027656","article-title":"Lipidomic profiling reveals protective function of fatty acid oxidation in cocaine-induced hepatotoxicity","volume":"53","author":"Shi","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bioorg.2025.109378_bb0385","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.lfs.2015.05.013","article-title":"Metabolome disruption of the rat cerebrum induced by the acute toxic effects of the synthetic cannabinoid MAM-2201","volume":"137","author":"Zaitsu","year":"2015","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.bioorg.2025.109378_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4299","article-title":"Metabolic alterations in triptolide-induced acute hepatotoxicity","volume":"32","author":"Zhao","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.bioorg.2025.109378_bb0395","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jep.2017.06.027","article-title":"Toxicological effects of Nux Vomica in rats urine and serum by means of clinical chemistry, histopathology and (1)H NMR-based metabonomics approach","volume":"210","author":"Fan","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0400","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jep.2013.06.039","article-title":"General toxicity of Pinellia ternata (Thunb.) Berit. in rat: a metabonomic method for profiling of serum metabolic changes","volume":"149","author":"Zhang","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109378_bb0405","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00204-021-03204-y","article-title":"Cardiotoxicity of cyclophosphamide's metabolites: an in vitro metabolomics approach in AC16 human cardiomyocytes","volume":"96","author":"Dionisio","year":"2022","journal-title":"Arch. Toxicol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109378_bb0410","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacbts.2019.10.008","article-title":"Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach?","volume":"4","author":"Van Norman","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73721-w","article-title":"Evaluation of the antitumor effects of PP242 in a colon cancer xenograft mouse model using comprehensive metabolomics and lipidomics","volume":"10","author":"Rashid","year":"2020","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.bioorg.2025.109378_bb0420","doi-asserted-by":"crossref","first-page":"13041","DOI":"10.1021\/acs.jmedchem.2c00880","article-title":"A photoactivated sorafenib-ruthenium(ii) prodrug for resistant hepatocellular carcinoma therapy through ferroptosis and purine metabolism disruption","volume":"65","author":"Lai","year":"2022","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0425","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nchembio.2517","article-title":"Metabolomics-based discovery of a metabolite that enhances oligodendrocyte maturation","volume":"14","author":"Beyer","year":"2018","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109378_bb0430","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nchembio.767","article-title":"Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin","volume":"8","author":"Patti","year":"2012","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0435","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12951-022-01465-y","article-title":"Abplatin((IV)) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin","volume":"20","author":"Li","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"24","key":"10.1016\/j.bioorg.2025.109378_bb0440","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413188","article-title":"Serum metabolomic and lipidomic profiling reveals novel biomarkers of efficacy for benfotiamine in Alzheimer's disease","volume":"22","author":"Bhawal","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0445","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11306-009-0168-0","article-title":"Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research","volume":"5","author":"Scalbert","year":"2009","journal-title":"Metabolomics"},{"issue":"Database issue","key":"10.1016\/j.bioorg.2025.109378_bb0450","doi-asserted-by":"crossref","first-page":"D521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the human metabolome database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0455","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/ajcn\/86.4.1016","article-title":"Diurnal variation in glutathione and cysteine redox states in human plasma","volume":"86","author":"Blanco","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109378_bb0460","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.trac.2008.01.008","article-title":"LC-MS-based methodology for global metabolite profiling in metabonomics\/metabolomics","volume":"27","author":"Theodoridis","year":"2008","journal-title":"TrAC Trends in Anal. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109378_bb0465","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1365-313X.2008.03434.x","article-title":"Metabolite annotations based on the integration of mass spectral information","volume":"54","author":"Iijima","year":"2008","journal-title":"Plant J."},{"key":"10.1016\/j.bioorg.2025.109378_bb0470","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.copbio.2018.07.010","article-title":"Challenges, progress and promises of metabolite annotation for LC-MS-based metabolomics","volume":"55","author":"Chaleckis","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bioorg.2025.109378_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2022.116903","article-title":"Advanced analytical and informatic strategies for metabolite annotation in untargeted metabolomics","volume":"158","author":"Cai","year":"2023","journal-title":"TrAC Trends in Anal. Chem."},{"key":"10.1016\/j.bioorg.2025.109378_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.841373","article-title":"Networks and Graphs Discovery in Metabolomics Data Analysis and Interpretation","volume":"9","author":"Amara","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"2","key":"10.1016\/j.bioorg.2025.109378_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8020031","article-title":"Software tools and approaches for compound identification of LC-MS\/MS data in metabolomics","volume":"8","author":"Blazenovic","year":"2018","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0490","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1021\/acs.analchem.9b04553","article-title":"Recent developments along the analytical process for metabolomics workflows","volume":"92","author":"Gonzalez-Riano","year":"2020","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109378_bb0495","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/mas.21489","article-title":"Mining molecular structure databases: Identification of small molecules based on fragmentation mass spectrometry data","volume":"36","author":"Hufsky","year":"2017","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.bioorg.2025.109378_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2018.11.022","article-title":"From mass to metabolite in human untargeted metabolomics: Recent advances in annotation of metabolites applying liquid chromatography-mass spectrometry data","volume":"120","author":"Nash","year":"2019","journal-title":"TrAC Trends in Analy. Chem."},{"issue":"49","key":"10.1016\/j.bioorg.2025.109378_bb0505","doi-asserted-by":"crossref","first-page":"16369","DOI":"10.1021\/acs.analchem.1c02826","article-title":"Cross-laboratory standardization of preclinical lipidomics using differential mobility spectrometry and multiple reaction monitoring","volume":"93","author":"Ghorasaini","year":"2021","journal-title":"Anal. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109378_bb0510","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.apsb.2023.05.021","article-title":"Metabolomics in drug research and development: The recent advances in technologies and applications","volume":"13","author":"Pang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.109378_bb0515","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3389\/fphar.2020.00858","article-title":"Untargeted metabolomic analysis of the effects and mechanism of nuciferine treatment on rats with nonalcoholic fatty liver disease","volume":"11","author":"Cui","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0520","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1021\/acs.analchem.9b04067","article-title":"Perspective on advances in laser-based high-resolution mass spectrometry imaging","volume":"92","author":"Wang","year":"2020","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0525","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21394-y","article-title":"Integrative multiomic analyses of dorsal root ganglia in diabetic neuropathic pain using proteomics, phospho-proteomics, and metabolomics","volume":"12","author":"Doty","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0530","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/acs.jproteome.7b00724","article-title":"Integrative proteomics-metabolomics strategy for pathological mechanism of vascular depression mouse model","volume":"17","author":"Zhao","year":"2018","journal-title":"J. Proteome Res."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109378_bb0535","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1074\/jbc.RA118.004964","article-title":"Metabolomics and proteomics identify the toxic form and the associated cellular binding targets of the anti-proliferative drug AICAR","volume":"294","author":"Douillet","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"31","key":"10.1016\/j.bioorg.2025.109378_bb0540","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.3748\/wjg.v27.i31.5171","article-title":"Molecular advances in pancreatic cancer: A genomic, proteomic and metabolomic approach","volume":"27","author":"Rajesh","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.bioorg.2025.109378_bb0545","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1053\/j.gastro.2019.02.037","article-title":"Real-time targeted genome profile analysis of pancreatic ductal adenocarcinomas identifies genetic alterations that might be targeted with existing drugs or used as biomarkers","volume":"156","author":"Singhi","year":"2019","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.bioorg.2025.109378_bb0550","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1074\/mcp.M116.058313","article-title":"Resolution Of novel pancreatic ductal adenocarcinoma subtypes by global phosphotyrosine profiling","volume":"15","author":"Humphrey","year":"2016","journal-title":"Mol. Cell. Proteomics"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109378_bb0555","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/1078-0432.CCR-19-1496","article-title":"The proteomic landscape of pancreatic ductal adenocarcinoma liver metastases identifies molecular subtypes and associations with clinical response","volume":"26","author":"Law","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"32","key":"10.1016\/j.bioorg.2025.109378_bb0560","doi-asserted-by":"crossref","first-page":"E4410","DOI":"10.1073\/pnas.1501605112","article-title":"Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors","volume":"112","author":"Daemen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0565","article-title":"Applications of multi-omics analysis in human diseases","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm (2020)"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/ht7040033","article-title":"From single level analysis to multi-omics integrative approaches: a powerful strategy towards the precision oncology","volume":"7","author":"Gallo Cantafio","year":"2018","journal-title":"High Throughput"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0575","doi-asserted-by":"crossref","DOI":"10.3390\/proteomes11040034","article-title":"Multi-Omics Integration for the Design of Novel Therapies and the Identification of Novel Biomarkers","volume":"11","author":"Ivanisevic","year":"2023","journal-title":"Proteomes"},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0580","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btad143","article-title":"Phenonaut: multiomics data integration for phenotypic space exploration","volume":"39","author":"Shave","year":"2023","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.bioorg.2025.109378_bb0585","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/bib\/bbz122","article-title":"An omics perspective on drug target discovery platforms","volume":"21","author":"Paananen","year":"2020","journal-title":"Brief. Bioinform."},{"issue":"9","key":"10.1016\/j.bioorg.2025.109378_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095213","article-title":"Challenges in metabolomics-based tests, biomarkers revealed by metabolomic analysis, and the promise of the application of metabolomics in precision medicine","volume":"23","author":"Di Minno","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109378_bb0595","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mas.21548","article-title":"Metabolomics toward personalized medicine","volume":"38","author":"Jacob","year":"2019","journal-title":"Mass Spectrom. Rev."},{"issue":"7","key":"10.1016\/j.bioorg.2025.109378_bb0600","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1021\/acs.jproteome.9b00755","article-title":"Bioinformatics analysis of metabolomics data unveils association of metabolic signatures with methylation in breast cancer","volume":"19","author":"Alakwaa","year":"2020","journal-title":"J. Proteome Res."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109378_bb0605","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","article-title":"Comprehensive metabolomics expands precision medicine for triple-negative breast cancer","volume":"32","author":"Xiao","year":"2022","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0610","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1586\/14789450.2015.989987","article-title":"Tremendous progress in proteomics and metabolomics in Central and Eastern Europe","volume":"12","author":"Gadher","year":"2015","journal-title":"Expert Rev. Proteomics"},{"issue":"9","key":"10.1016\/j.bioorg.2025.109378_bb0615","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s11548-025-03476-0","article-title":"Anomaly detection using intraoperative iKnife data: a comparative analysis in breast cancer surgery","volume":"20","author":"Radcliffe","year":"2025","journal-title":"Int. J. Comput. Assist. Radiol. Surg."},{"issue":"13","key":"10.1016\/j.bioorg.2025.109378_bb0620","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1073\/pnas.1916960117","article-title":"The intelligent knife (iKnife) and its intraoperative diagnostic advantage for the treatment of cervical disease","volume":"117","author":"Tzafetas","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"23","key":"10.1016\/j.bioorg.2025.109378_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235892","article-title":"Point-of-care diagnosis of endometrial cancer using the surgical intelligent knife (iKnife)-A prospective pilot study of diagnostic accuracy","volume":"14","author":"Marcus","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bioorg.2025.109378_bb0630","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.650318","article-title":"Depression from a precision mental health perspective: utilizing personalized conceptualizations to guide personalized treatments","volume":"12","author":"Deif","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.bioorg.2025.109378_bb0635","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-981-97-4402-2_18","article-title":"Precision medicine in depression: the role of proteomics and metabolomics in personalized treatment approaches","volume":"1456","author":"Jaber","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.109378_bb0640","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042032","article-title":"Adaptation of lipid profiling in depression disease and treatment: a critical review","volume":"23","author":"Pinto","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2025.109378_bb0645","article-title":"Metabolomics of major depressive disorder: a systematic review of clinical studies","volume":"14","author":"Costa","year":"2022","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.bioorg.2025.109378_bb0650","article-title":"Evaluation of serum lysophosphatidic acid and lysophosphatidylcholine levels in major depressive disorder patients","volume":"12","author":"Riya","year":"2020","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.bioorg.2025.109378_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01699","article-title":"Lysophosphatidic acid levels in cerebrospinal fluid and plasma samples in patients with major depressive disorder","volume":"5","author":"Gotoh","year":"2019","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.bioorg.2025.109378_bb0660","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12291-010-0016-z","article-title":"Clinical correlation of alteration of endogenous antioxidant-uric acid level in major depressive disorder","volume":"25","author":"Chaudhari","year":"2010","journal-title":"Indian J. Clin. Biochem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.109378_bb0665","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/s41591-022-01992-z","article-title":"Simultaneous prediction of risk for multiple common diseases using metabolomics","volume":"28","author":"Buergel","year":"2022","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2025.109378_bb0670","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1042\/EBC20160030","article-title":"The application of metabolomics for herbal medicine pharmacovigilance: a case study on ginseng","volume":"60","author":"Crighton","year":"2016","journal-title":"Essays Biochem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825012581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:07:45Z","timestamp":1773929265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825012581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":134,"alternative-id":["S0045206825012581"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109378","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomics accelerates drug development and facilitates the discovery of new targets, mechanisms and structures","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109378"}}